We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Andrx and Takeda Pharmaceuticals have filed a new drug application (NDA) for a combination product to treat Type 2 diabetes, the companies said April 4.